CHBOF'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: -88.32 Med: -27.94 Max: 76.35
Current: 53.79
During the past 13 years, China Health Technology Group Holding Co's highest Return-on-Tangible-Equity was 76.35%. The lowest was -88.32%. And the median was -27.94%.
CHBOF's Return-on-Tangible-Equity is ranked better than 97.85% of 279
companies
in the Forest Products industry
Industry Median: 2.17
vs CHBOF: 53.79
China Health Technology Group Holding Co (OTCPK:CHBOF) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
China Health Technology Group Holding Co Return-on-Tangible-Equity Related Terms
China Health Technology Group Holding Co Return-on-Tangible-Equity Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
China Health Technology Group Holding Co Return-on-Tangible-Equity Chart
China Health Technology Group Holding Co Annual Data
CHBOF vs SSD, UFPI, BCC: Return-on-Tangible-Equity Comparison
For the Lumber & Wood Production subindustry, China Health Technology Group Holding Co's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
China Health Technology Group Holding Co Return-on-Tangible-Equity vs Forest Products Industry
For the Forest Products industry and Basic Materials sector, China Health Technology Group Holding Co's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where China Health Technology Group Holding Co's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is two times the semi-annual (Dec. 2025) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 20.46% mean?
China Health Technology Group Holding Co (CHBOF) has a Return-on-Tangible-Equity of 20.46% as of Dec. 2025. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on China Health Technology Group Holding Co and its competitors. According to the industry distribution chart, China Health Technology Group Holding Co ranks #6 out of 279 companies in the Forest Products industry, placing it in the top 2.2%.
Is China Health Technology Group Holding Co's Return-on-Tangible-Equity too high?
China Health Technology Group Holding Co's current Return-on-Tangible-Equity is 20.46%. The Forest Products industry median Return-on-Tangible-Equity is 2.17. China Health Technology Group Holding Co's value of 20.46% is 842.9% above this industry median. Based on the distribution chart, China Health Technology Group Holding Co ranks #6 out of 279 companies in the Forest Products industry, which is in the top quartile — a strong position relative to peers. Overall, China Health Technology Group Holding Co has a GF Score™ of 25/100, reflecting its overall financial health beyond just this single metric.
How does China Health Technology Group Holding Co's Return-on-Tangible-Equity compare to SSD and UFPI?
According to the Forest Products industry distribution chart, China Health Technology Group Holding Co ranks #6 out of 279 companies for Return-on-Tangible-Equity. This places China Health Technology Group Holding Co in the top 2% of its industry — outperforming the majority of peers. The industry median Return-on-Tangible-Equity is 2.17. China Health Technology Group Holding Co's value of 20.46% is 842.9% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Forest Products company?
The median Return-on-Tangible-Equity among Forest Products companies is 2.17, based on 279 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. China Health Technology Group Holding Co's current Return-on-Tangible-Equity of 20.46% is 842.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on China Health Technology Group Holding Co and its competitors. For the Forest Products industry, the median Return-on-Tangible-Equity is 2.17 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. China Health Technology Group Holding Co's current Return-on-Tangible-Equity is 20.46%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China Health Technology Group Holding Co stock overvalued right now?
China Health Technology Group Holding Co (CHBOF) has a current Return-on-Tangible-Equity of 20.46%. The stock's GF Value™ is $0.05, compared to a current price of $0.03 — trading 34.1% below its estimated fair value. The current Return-on-Tangible-Equity is 20.46% and 842.9% above the Forest Products industry median of 2.17. China Health Technology Group Holding Co's overall GF Score™ is 25/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For China Health Technology Group Holding Co (CHBOF), the current Return-on-Tangible-Equity is 20.46% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is China Health Technology Group Holding Co (CHBOF) Overvalued in 2026?
Based on GuruFocus' analysis, China Health Technology Group Holding Co stock appears to be undervalued.
The current stock price of $0.03 is trading 34.1% below its estimated GF Value™ of $0.05.
Key valuation signals for CHBOF:
Return-on-Tangible-Equity: 20.46%
GF Value™: $0.05 vs. price of $0.03 (34.1% below fair value)
Industry Position: 842.9% above the Forest Products median (#6 of 279)
No single metric tells the full story. See the CHBOF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
China Health Technology Group Holding Co Business Description
China Health Technology Group Holding Co Ltd is an investment holding company. It is engaged in the business of management of new agriculture and forestry resources in the People's Republic of China. The company has reportable segments including the Forestry business; Horny Goat Weed Business; Health products business and Ginseng Business. The forestry management business includes plantation, logging, and sale of timber-related products and the Ginseng Business includes ginseng plantation and trading of related products. The company generates a majority of its revenue from the Forestry business segment. Geographically company generates its key revenue from the PRC.
25GF Score
Get the complete analysis for CHBOF
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHBOF has been successfully added to your 
